Sprout Health review

The costs at a glance

My take: the current homepage gives a useful billing distinction

I would compare Sprout using the current homepage’s four-week rate and separate annual prepayment, rather than blend several campaign prices into one offer. The site clearly distinguishes $149 per four weeks from a lower annual monthly equivalent for semaglutide. That is useful information. The limitation is that older campaign and policy pages describe other rates or billing cadences, so the selected checkout still needs to identify the actual agreement. I would keep the payment interval visible wherever the price appears and evaluate the annual commitment as a separate choice.

Four weeks is not a calendar month

Sprout’s current homepage lists compounded semaglutide at $149 every four weeks or $1,188 upfront for a twelve-month program, equivalent to $99 monthly. Tirzepatide is listed at $199 every four weeks or $1,788 upfront annually. I would compare matching periods and show the full annual payment next to its equivalent. A four-week plan can create more renewal periods than calendar-month billing. Do not treat the annual rate as a monthly invoice or assume the smaller repeated payment and the longer prepayment carry identical flexibility. Make the cost comparison concrete with our complete-cost guide.

Several campaign paths need a selected-order check

An alternate campaign advertises different introductory and quarterly figures. The refund page also describes monthly, three-month and six-month plans, while the current homepage includes four-week and annual options. I would ask which terms and renewal interval apply to the order you are considering, then save that quote. Marketing paths can coexist without describing an identical product or period, but the reader needs one coherent purchase. Comparing the current homepage is a sound starting point; it is not permission to assume every campaign uses its same rate and cadence.

Provider review comes before a prescription is fulfilled

Sprout describes an online evaluation by an independent licensed clinician and pharmacy fulfillment only if treatment is appropriate. The home page says most prescriptions are sent to the pharmacy within two business days after the visit. I would treat that as a process description, not a guaranteed arrival date. Ask which practice handles follow-up and how to request a live review. If the clinician needs more information, the timeline may change. A quick assessment should not be confused with approval for a specific medicine or permission to continue an old prescription unchanged.

The refund policy distinguishes unprocessed and pharmacy-stage orders

The policy describes a full refund before the prescription is sent to the pharmacy, and a nonrefundable stage after that handoff. It separately describes refunding unshipped months in an early-ended multi-month plan using the amount actually paid. I would have support explain how those provisions apply to the selected annual or shorter purchase. A refund rule for remaining shipments is not the same as returning a dispensed prescription. Keep the current order status and future subscription cancellation separate when making a request, especially during a transfer of care. Compare the exit conditions using our cancellation and refund guide.

A shipping delay request has its own lead time

Sprout asks for shipment-delay requests at least five business days before the scheduled ship date. I would calendar that alongside renewal, because pausing delivery and stopping a charge can involve different stages. The policy also asks readers to report delivery-condition concerns within 24 hours with photographs. Arrange to inspect a package promptly and contact the pharmacy about product-specific handling questions. FDA cautions against using injectable GLP-1 medicine arriving warm or inadequately refrigerated, so a generic reassurance about ice packs should not replace an assessment of the actual shipment.

The compounded category is explicit

The homepage identifies compounded semaglutide and tirzepatide and says they are neither brand-name drugs nor generics approved by FDA. I would preserve that distinction when comparing Sprout with a branded-prescription route. FDA says compounding should be considered when an approved option cannot meet a patient’s needs. Ask the clinician to explain the proposed preparation, then obtain the actual pharmacy and corresponding instructions. A flat rate across doses is a commercial feature; it is not an instruction to choose a dose or evidence that a compound matches the results of an approved-product trial.

Who I would compare Sprout for

I would compare Sprout for a reader who wants published compounded-plan pricing and is willing to compare shorter renewals with a substantial annual payment. I would be more cautious if the decision relies on an older campaign discount or assumes every advertised month is a calendar month. Confirm the selected invoice, period, refund rules and clinical contact route, then compare the same supply and care needs with an alternative. My assessment comes from the public commercial pages and does not claim a personal purchase, treatment experience or verified pharmacy performance. Compare the payment and follow-up structure in our Good Life Meds review before settling on a service.

Before you sign up

• Does this order renew every four weeks or on another cadence?
• What refund rule applies to unused annual shipments?
• When must I request a shipment delay or report a delivery concern?

Use the answers to compare the exact offer with another provider. A service review cannot determine whether a medication is appropriate for you; that decision belongs with your clinician.